Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ CompletedNot Applicable Multicenter Efficacy Trial of the Serene RF System for the Reduction of Glabellar Lines
The purpose of this study is to evaluate the ability of the Serene RF System to effectively improve the appearance of dynamic glabellar lines and sustain the effect for a minimum of 3 months.
100 Clinical Results associated with Serene Medical, Inc.
0 Patents (Medical) associated with Serene Medical, Inc.
100 Deals associated with Serene Medical, Inc.
100 Translational Medicine associated with Serene Medical, Inc.